A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes.
Curtin F, Champion B, Davoren P, Duke S, Ekinci EI, Gilfillan C, Morbey C, Nathow T, O'Moore-Sullivan T, O'Neal D, Roberts A, Stranks S, Stuckey B, Vora P, Malpass S, Lloyd D, Maëstracci-Beard N, Buffet B, Kornmann G, Bernard C, Porchet H, Simpson R.
Curtin F, et al.
Diabetes Obes Metab. 2020 Jul;22(7):1111-1121. doi: 10.1111/dom.14010. Epub 2020 Mar 12.
Diabetes Obes Metab. 2020.
PMID: 32077207
Clinical Trial.